Navigation Links
Queen's study shows psychotropic drug dispensing increases on entry to care homes
Date:2/20/2013

A study by Queen's University Belfast has found that the dispensing of psychotropic drugs to older people in Northern Ireland increases on entry to care homes.

According to the study, due to be published in the Journal of the American Geriatrics Society, antipsychotic drug dispensing in older people more than doubled from 8.2 per cent before entry to care homes to 18.6 per cent after entering care.

The study was carried out by researchers from Queen's Centre for Public Health in the School of Medicine, Dentistry and Biomedical Sciences. It analysed prescribing data for over 250,000 people, aged 65 years and over living in Northern Ireland from 2008 to 2010, and looked at drug uptake within the older population during the transition from community to care.

The study revealed that psychotropic drug use was higher in care homes than the community, with 20.3 per cent of those in care homes dispensed an antipsychotic in January 2009, compared with 1.1 per cent of those in the community.

Lead researcher on the Queen's study, Aideen Maguire, who is based in the Centre of Excellence for Public Health Northern Ireland said: "Although drug dispensing is high in older people in the community, we have found that it increases dramatically on entry to care. This study showed that the high uptake of psychotropic drugs observed in care homes in Northern Ireland cannot be explained by a continuation of drug use initiated in the community prior to entering care.

"With an ageing population globally it is important that we look at the reasons behind this type of increase following admission to care. Antipsychotic uptake in Northern Ireland is similar to that in the rest of the UK and Ireland, and this study highlights the need for routine medicines reviews especially during the transition into care."

Other key findings of the study included:

  • Of the 250,617 people studied, 6,779 (2.7 per cent) experienced a transition into care during 2008-2010.
  • The psychotropic drugs prescribed to patients included in the study were being prescribed for the first time for many.
  • Six months after admission, 37.1 per cent of all new residents had received at least one prescription for a hypnotic drug, 30.2 per cent for an antipsychotic, and 24.5 per cent for an anxiolytic.
  • 1.1 per cent of those living in the community were dispensed at least one prescription for an antipsychotic in January 2009, (7.3 per cent for a hypnotic, and 3.6 percent for an anxiolytic).
  • Hypnotic drug dispensing increased from 14.8 per cent to 26.3 per cent after entering care.
  • This study shows that use of psychotropic medication in a small proportion of residents of care homes was a continuation of a prescription that had been started before entry, but one in six individuals with no history of psychotropic drug use in the six months before entry had been exposed to at least one antipsychotic prescription within six months of entering care.

Professor Carmel Hughes from the School of Pharmacy at Queen's added: "This is an important study of national and international relevance, as with an ageing population, quality of care for older people is an ongoing public health concern.

"The number of older people entering care across Ireland is predicted to increase in the next 10 years, and studies further predict a 69 per cent increase in the Irish population aged over 65 years from 2006-2021, and a 40 per cent increase in the those aged over 65 years in Northern Ireland in the same time frame. With a globally ageing population, it is vitally important that we look at the reasons behind the increase in the prescription of psychotropic drugs in care homes."


'/>"/>

Contact: Claire O'Callaghan
c.ocallaghan@qub.ac.uk
Queen's University Belfast
Source:Eurekalert

Related medicine news :

1. Independence Residences Inc. Announces Affiliation with Queens Parent Resource Center (QPRC)
2. Study Suggests Vaccine May Help Kids With Brain Cancer
3. Study reveals how cancer drug causes diabetic-like state
4. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
5. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
6. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
7. No Added Cancer Risk From Hip Replacement Materials: Study
8. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
9. Early Study Finds Some Promise for Lung Cancer Vaccine
10. Narcissists Often Ace Job Interviews, Study Finds
11. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... Canadian Zeolite ... that a two year study conducted by the University of Saskatchewan in partnership ... in remediating potash brine-impacted groundwater. As a part of the study, batch adsorption ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... financial consultations to communities in northern Virginia and DC, is announcing a cooperative ... for patients with Alzheimer’s and other disorders that lead to memory impairment. , ...
(Date:6/27/2017)... ... June 27, 2017 , ... Nearly 70 ... survey data released today by the American Society for Dermatologic Surgery ... the percentage of consumers considering a cosmetic medical procedure has doubled since 2013. ...
(Date:6/27/2017)... ... June 27, 2017 , ... Salucro, the cloud-based payment ... care industry’s hospitals and provider groups, has announced that it will now offer ... Health is a San Francisco health-finance startup that has launched a series of ...
(Date:6/27/2017)... ... June 27, 2017 , ... From June 20-22, EarQ and Widex ... Syracuse, New York, where EarQ is headquartered. , Together, the organizations educate hearing ... today’s savvy consumer, and the latest in hearing technology. At the event, EarQ ...
Breaking Medicine News(10 mins):
(Date:6/27/2017)...  Therapix Biosciences Ltd. (Nasdaq: TRPX ) ... development of cannabinoid-based drugs, today announced that the Company ... New York, NY on Wednesday, ... offering (IPO) of American Depository Shares (ADSs) listed on ... Dr. Elran Haber, Ph.D., Chief Executive Officer of Therapix, ...
(Date:6/27/2017)... --  NuEyes (NuEyes Technologies Inc.) today announced that it ... in helping the legally blind live more independent lives. NuEyes works ... developer of augmented, virtual and mixed reality smartglasses and the ... funding amount was provided by strategic partners as well as ... Abu Dhabi , New York ...
(Date:6/20/2017)... Netherlands and LAGUNA HILLS, Calif. ... the presentation of new data that validate the use ... risk stratify patients with multiple myeloma (MM). In a ... the European Hematology Association (EHA) in Madrid, ... value of MMprofiler for identifying high-risk elderly patients. ...
Breaking Medicine Technology: